SCOPUS 정보 검색 플랫폼

Clinical Cancer Research

Volumn 7, Issue 2, 2001, Pages 229-230

Why drugs fail: Of mice and men revisited

(1) Takimoto, C H a

a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ACTIVITY; EDITORIAL; PRIORITY JOURNAL; TREATMENT FAILURE; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; CAMPTOTHECIN; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; HUMANS; MICE; NEOPLASMS; TISSUE DISTRIBUTION;

EID: 0035120420 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Editorial

Times cited : (42)

References (14)

1
- 0035127478
- Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts
- (2001) Clin. Cancer Res. , vol.7
- Kirstein, M.N.¹ Houghton, P.J.² Cheshire, P.J.³ Richmond, L.B.⁴ Smith, A.K.⁵ Hanna, S.K.⁶ Stewart, C.F.⁷

2
- 0024358188
- DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts
- (1989) Science (Washington DC) , vol.246 , pp. 1046-1048
- Giovanella, B.C.¹ Stehlin, J.S.² Wall, M.E.³ Wani, M.C.⁴ Nicholas, A.W.⁵ Liu, L.F.⁶ Silber, R.⁷ Potmesil, M.⁸

3
- 0026694680
- Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins
- (1992) Cancer Res. , vol.52 , pp. 3980-3987
- Pantazis, P.¹ Hinz, H.R.² Mendoza, J.T.³ Kozielski, A.J.⁴ Williams L.J., Jr.⁵ Stehlin J.S., Jr.⁶ Giovanella, B.C.⁷

4
- 0027471350
- Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between nontumorigenic and tumorigenic cells in vitro
- (1993) Int. J. Cancer , vol.53 , pp. 863-871
- Pantazis, P.¹ Kozielski, A.J.² Mendoza, J.T.³ Early, J.A.⁴ Hinz, H.R.⁵ Giovanella, B.C.⁶

5
- 0028904703
- A Phase I and pharmacokinetic study of a new camptothecin derivative, 9-aminocamptothecin
- (1995) Clin. Cancer Res. , vol.1 , pp. 269-276
- Rubin, E.¹ Wood, V.² Bharti, A.³ Trites, D.⁴ Lynch, C.⁵ Hurwitz, S.⁶ Bartel, S.⁷ Levy, S.⁸ Rosowsky, A.⁹ Toppmeyer, D.¹⁰

6
- 9244231199
- Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients
- (1996) J. Clin. Oncol. , vol.14 , pp. 1236-1244
- Dahut, W.¹ Harold, N.² Takimoto, C.³ Allegra, C.⁴ Chen, A.⁵ Hamilton, J.M.⁶ Arbuck, S.⁷ Sorensen, M.⁸ Grollman, F.⁹ Nakashima, H.¹⁰ Lieberman, R.¹¹ Liang, M.¹² Corse, W.¹³ Grem, J.¹⁴

7
- 0006097092
- Phase II and pharmacokinetic (PK) study of 9-aminocamptothecin (9AC) in recurrent epithelial ovarian cancer
- (1999) Proc. Am. Soc. Clin. Oncol. , vol.18
- McCarthy, N.¹ Sarosy, G.² Minasian, L.³ Davis, P.⁴ Tompkins, A.⁵ Dyer, V.⁶ Jones-Wells, A.⁷ Smith, J.⁸ Kohler, D.⁹ Takimoto, C.¹⁰ Figg, W.D.¹¹ Kohn, E.C.¹² Reed, E.¹³

8
- 0031803410
- Phase II and dose-escalation with or without granulocyte colony-stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomas
- published erratum appears in J. Clin. Oncol., 16: 2895, 1998
- (1998) J. Clin. Oncol. , vol.16 , pp. 2345-2351
- Wilson, W.H.¹ Little, R.² Pearson, D.³ Jaffe, E.S.⁴ Steinberg, S.M.⁵ Cheson, B.D.⁶ Humphrey, R.⁷ Kohler, D.R.⁸ Elwood, P.⁹

9
- 7844228404
- A Phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer
- (1998) Ann. Oncol. , vol.9 , pp. 1085-1090
- Vokes, E.E.¹ Ansari, R.H.² Masters, G.A.³ Hoffman, P.C.⁴ Klepsch, A.⁵ Ratain, M.J.⁶ Sciortino, D.F.⁷ Lad, T.E.⁸ Krauss, S.⁹ Fishkin, P.A.¹⁰ Golomb, H.M.¹¹

10
- 0032457859
- Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for 3 weeks in metastatic colorectal carcinoma
- (1998) Investig. New Drugs , vol.16 , pp. 341-346
- Pazdur, R.¹ Medgyesy, D.C.² Winn, R.J.³ Dakhil, S.R.⁴ Moore D.F., Jr.⁵ Scalzo, A.⁶ Hoff, P.M.⁷ Arbuck, S.G.⁸ Abbruzzese, J.L.⁹

11
- 0031773306
- Rational design of irinotecan administration based on preclinical models
- (1998) Oncology (Huntingt.) , vol.12 , pp. 22-30
- Minderman, H.¹ Cao, S.² Rustman, Y.M.³

12
- 0031054593
- Differential toxicity of camptothecin, topotecan, and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU- GM) in vitro
- (1997) Cancer Chemother. Pharmacol. , vol.39 , pp. 467-472
- Erickson-Miller, C.L.¹ May, R.D.² Tomaszewski, J.³ Osborn, B.⁴ Murphy, M.J.⁵ Page, J.G.⁶ Parchment, R.E.⁷

13
- 0031742751
- Extending principles learned in model systems to clinical trials design
- (1998) Oncology (Huntingt.) , vol.12 , pp. 84-93
- Houghton, P.J.¹ Stewart, C.F.² Thompson, J.³ Santana, V.M.⁴ Furman, W.L.⁵ Friedman, H.S.⁶

14
- 0032054147
- Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts
- (1998) J. Natl. Cancer Inst. , vol.90 , pp. 505-511
- Zamboni, W.C.¹ Stewart, C.F.² Thompson, J.³ Santana, V.M.⁴ Cheshire, P.J.⁵ Richmond, L.B.⁶ Luo, X.⁷ Poquette, C.⁸ Houghton, J.A.⁹ Houghton, P.J.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.